Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Car t-cell therapy directed to LHR for the treatment of solid tumors

Car t-cell therapy directed to LHR for the treatment of solid tumors

US Patent 11136401 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Fluid applicator cap2023
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Gene expression panel for prognosis of prostate cancer recurrence2021
CD20 scFv-ELPs methods and therapeutics2021
CD20 scFv-ELPs methods and therapeutics2021
Lym-1 and Lym-2 targeted CAR cell immunotherapy2020
Gene expression panel for prognosis of prostate cancer recurrence2019